VANCOUVER, BRITISH COLUMBIA--(Marketwire - Feb. 19, 2008) - Med BioGene Inc. (TSX VENTURE:MBI), a life science company focused on the development and commercialization of genomic-based diagnostic tests for cancer and cardiovascular disease, is pleased to announce that Dennis L. Grimaud has joined the company's Board of Directors.
